PBGH Announcements

Coalition Advocates for Biosimilar Uptake to Help Lower Employers’ Drug Cost Burden

Rising drug costs in the United States are a pressing concern not only for patients who need to receive those drugs, but also for employers. The Employers’ Prescription for Affordable Drugs (EmployersRx) is a coalition that aims to tackle this problem by working with policy makers and stakeholders to encourage and facilitate more transparency, competition, and value in the healthcare system.

Lisa Zamosky joins PBGH as Chief Communications Officer

Lisa Zamosky joins PBGH on January 20, 2020 as Chief Communications Officer. Lisa brings extensive communications and healthcare expertise to PBGH, where she will help accelerate PBGH’s vision of improving health outcomes, experience, and affordability for consumers and purchasers.

PBGH issues statement on Sutter Health settlement

Read the statement issued by PBGH CEO Elizabeth Mitchell on the settlement of the lawsuit against Sutter Health System regarding alleged consolidation practices.

Susan Au, CPA, MBA joins PBGH as Chief Financial Officer

Susan Au, CPA, MBA joins PBGH on January 27, 2020 as Chief Financial Officer.

PBGH launches EmployersRx

PBGH has launched the Employers’ Prescription for Affordable Drugs (EmployersRx), a coalition uniting employers in advocacy for policies that will address our nation’s biggest health care challenge—the high cost of prescription drugs.

Health Equity, COVID-19: Large Employers’ Response to Crises

The Pacific Business Group on Health (PBGH) recently asked our members to take part in a poll to assess their plans to support workers with young children unable to return to school due to the COVID-19 health crisis and to address the health inequities that COVID-19 has exacerbated.

POSTPONED: Biosimilars – The Next Frontier, April 22

This event has been postponed to a later date.